Gilead tags along again to support cell therapy biotech Kyverna in $85M fundraising
Gilead tags along again to support cell therapy biotech Kyverna [...]
Pfizer, BioNTech launch trial for potential omicron-busting vaccine
Pfizer, BioNTech launch trial for potential omicron-busting vaccine aarmstrong Tue, [...]
Sierra’s bet on Gilead castoff pays off, teeing up FDA filing for rival to Incyte-Novartis cancer drug
Sierra’s bet on Gilead castoff pays off, teeing up FDA [...]
AstraZeneca success torpedoes PCI’s pivotal plan, crushing stock
AstraZeneca success torpedoes PCI’s pivotal plan, crushing stock ntaylor Tue, [...]
New clinical trial organization launches with promise to conduct randomized trials at fraction of the cost
New clinical trial organization launches with promise to conduct randomized [...]
1b, or not 1b: FDA hits Viking with clinical hold over mix-up in phase of rare disease trial
1b, or not 1b: FDA hits Viking with clinical hold [...]
MaaT wraps up cancer microbiome trial early to power into phase 2/3 this year
MaaT wraps up cancer microbiome trial early to power into [...]
Alnylam touts data replication for next-generation Onpattro in ATTR trial but analysts pour some cold water
Alnylam touts data replication for next-generation Onpattro in ATTR trial [...]
MD Anderson inks deal to put Chinese cancer drugs through trials, starting with a PI3K inhibitor
MD Anderson inks deal to put Chinese cancer drugs through [...]
Kura exits FDA clinical hold after agreeing to mitigation measures, enabling resumption of blood cancer trial
Kura exits FDA clinical hold after agreeing to mitigation measures, [...]